Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique (Amplicon Based Approach, Hybridization Based Approach), By Design, By Application, By End Use, By Region, And Segment)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Gene Panel Market Size and Growth Analysis Report 2033

The global gene panel market size was USD 3.19 billion in 2023, calculated at USD 3.76 billion in 2024 and is expected to reach around USD 16.42 billion by 2033, expanding at a CAGR of 17.8% from 2024 to 2033.

Gene Panel Market Key Takeaways

• North America gene panel market dominated the global gene panel market with a share of 36.17% in 2023.
• The gene panel market in the U.S. dominated the North America gene panel market with a share of 71.27% in 2023
• Asia Pacific gene panel market is projected to register the fastest CAGR of 19.6% over the forecast period
• Test kits dominated the market and accounted for revenue share of 60.19% in 2023
• Testing services are expected to witness the fastest growth at a CAGR of 18.0% over the forecast period
• Amplicon-based approach dominated the market and accounted for a share of 79.12% in 2023.
• The hybridization-based approach is expected to grow at a significant rate over the forecast period
• Predesigned gene panels dominated the market and accounted for revenue share of 66.19% in 2023
• Customized gene panels are expected to register substantial growth over the forecast period.
• Cancer risk assessment accounted for the largest market share of 54.29% in 2023.
• The diagnosis of congenital diseases is expected be the fastest-growing market application with a 20.4% CAGR over the forecast period.
• The academic & research institutes segment had the highest revenue share in 2023, accounting for 42.14% of the total revenue.
• The pharmaceutical & biotechnology companies segment is projected to witness the most lucrative growth rate of 22.8% between 2024 and 2033.

Gene Panel Market Growth 

The market is experiencing rapid expansion due to factors such as the rising prevalence of hereditary disorders and cancer, increasing need for genetic screening, and changing guidelines for genetic screening to proactively reduce mortality rates from genetic disorders. Moreover, identifying the genetic predisposition for various types of cancer or other genetic disorders has become the primary approach for clinicians to advance disease prognosis and treatment.

The increasing adoption of gene panels in cancer-focused treatments is the primary driver of market growth. In line with market expansion and developments, the market shows substantial promise in meeting the unmet diagnostic and therapeutic requirements for chronic illnesses, especially in the realm of cancer. As the number of deaths related to cardiovascular diseases, diabetes, and arthritis rises among adults with various chronic ailments, there is a critical need for advanced diagnostic services. These services integrate clinically significant target sequences into NGS tests, providing a hopeful resolution.

According to the National Institutes of Health, approximately 7,000 rare diseases affect around 25-30 million people in the U.S. Many gene panels are specifically designed to identify genetic conditions at birth, facilitating early diagnosis and treatment strategies. Moreover, genetic testing allows for the detection of altered genes linked to different illnesses, opening doors for the creation of specific treatments.

Various medical fields, such as oncology, pharmacology, and cardiology, are expected to be impacted by the progress in genetics. The increasing funding in R&D from pharmaceutical firms highlights the market's promising future. To sum up, the industry is set to transform the diagnostic field by delivering precise and prompt data, ultimately enhancing patient results.

Gene Panel Market Report Scope

Gene Panel Market By Product & Service Insights & Trends

Test kits dominated the market and accounted for revenue share of 60.19% in 2023. Genetic testing kits are ideal for identifying genetic mutations in genes, chromosomes, or proteins. To meet consumer demand for at-home testing, key competitors introduced Direct-to-Consumer test kits, driving segment growth. Regulatory approvals and increasing clinical trials also contributed to the segment's dominance.

Testing services are expected to witness the fastest growth at a CAGR of 18.0% over the forecast period, driven by the increasing demand for comprehensive genetic analysis and diagnosis of rare and complex disorders. Genetic testing services provide a customized approach, allowing clinicians to investigate specific genes or genomic regions of interest, driven by research and development activities, personalized medicine, and improving disease understanding.

Gene Panel Market By Techniques Insights & Trends

Amplicon-based approach dominated the market and accounted for a share of 79.12% in 2023. The continued product launches by the key players using this technology are expected to drive the segment growth. Amplicon-based gene panels are favored due to their reliability, reproducibility, and ability to analyze a large number of genes, making them a preferred technique in the gene panel market.

The hybridization-based approach is expected to grow at a significant rate over the forecast period, driven by their suitability for comprehensive genetic analysis and diagnosis of complex genetic disorders. As disease genetics understanding advances, demand for this approach is likely to increase, driven by its ability to provide detailed insights into genetic complexities.

Gene Panel Market By Design Insights & Trends

Predesigned gene panels dominated the market and accounted for revenue share of 66.19% in 2023, driven by their widespread adoption among clinicians due to their research-backed design and understanding of genetic predispositions to various disorders. Predesigned panels offer comprehensive genetic analysis, whereas customized panels are typically used for rare disorder diagnosis or specialized research. The increasing global incidence of genetic disorders and cancer is fueling demand for these well-researched predesigned gene panels, enabling timely diagnosis and personalized treatment approaches.

Customized gene panels are expected to register substantial growth over the forecast period. Customized gene panels excel at analyzing specific gene pathways, particularly useful for researching illnesses affecting particular pathways. They identify individual variations, enabling diagnosis, outcome prediction, patient management, and genetic counseling for inherited disorders. Technologies such as Ion AmpliSeq use ultrahigh multiplex PCR to amplify targeted regions with high sensitivity.

Gene Panel Market By Application Insights & Trends

Cancer risk assessment accounted for the largest market share of 54.29% in 2023. The increasing global cancer incidence and the advantages of gene panels, including their minimally invasive nature, are driving demand. As a result, gene panels are being used to replace multiple tests for cancer screening, particularly in populations with hereditary risk factors, allowing for the identification of genetic risk factors for various cancer types.

The diagnosis of congenital diseases is expected be the fastest-growing market application with a 20.4% CAGR over the forecast period. The rising prevalence of these conditions will drive growth, as early diagnosis enables timely prognosis and therapeutic intervention to improve quality of life. Growing understanding of heredity and increased genetic screening needs are also propelling adoption in hospitals and diagnostic labs.

Gene Panel Market By End Use Insights & Trends

The academic & research institutes segment had the highest revenue share in 2023, accounting for 42.14% of the total revenue. This is attributed to the growing global incidence of genetic disorders and cancer, which has led to increased research and development activities in this field. Universities and genetic research institutions are driving advancements in genomic technologies and discovering new applications for gene panels.

The pharmaceutical & biotechnology companies segment is projected to witness the most lucrative growth rate of 22.8% between 2024 and 2033. This is driven by increasing demand for gene panels to support cancer therapy development and the growing understanding of genetic disease mechanisms, leading to increased R&D investments and adoption of gene panels for personalized treatments.

Gene Panel Market By Regional Insights & Trends

North America gene panel market dominated the global gene panel market with a share of 36.17% in 2023. The research on cancer and inherited rare diseases in the region has witnessed a significant surge, accompanied by a notable increase in the number of NGS-based and clinical applications. Moreover, the presence of leading NGS providers in this region, coupled with the growing government support for genomics research, has further propelled advancements in this field.

U.S. Gene Panel Market Trends

The gene panel market in the U.S. dominated the North America gene panel market with a share of 71.7% in 2023 due to comprehensive studies conducted in multiple research facilities, jointly sponsored by academic institutions, pharmaceutical companies, and the National Cancer Institute, facilitating widespread adoption and growth.

Europe Gene Panel Market Trends

Europe gene panel market was identified as a profitable region in the industry, driven by supportive government policies, regulations, and incentives that promote the adoption of gene panel technology, such as subsidies for renewable energy initiatives and carbon pricing mechanisms, which contribute to market growth.

The gene panel market in the UK is impacted by the British government’s demonstration of a resolute dedication to the progression of genomic healthcare and research. Notably, the NHS in England has become the pioneer in providing whole genome sequencing as a standard component of routine care, making it the first healthcare service globally to do so.

Asia Pacific Gene Panel Market Trends

Asia Pacific gene panel market is projected to register the fastest CAGR of 19.6% over the forecast period, driven by increasing healthcare expenditure, technological advancements, and growing demand for genetic testing. The region is witnessing increased adoption for applications like cancer risk assessment, congenital disease diagnosis, and pharmacogenomics, fueled by expanding healthcare infrastructure, awareness, and rising incidence of genetic disorders and cancer.

The gene panel market in China is expected to grow rapidly in the coming years due to the growing demand of genetic screening. Genetic panels have become a popular choice for genetic screening due to their ability to efficiently and affordably screen for multiple genetic mutations at once.

Gene Panel Market Key Company Insights

Key market players are competing on product innovation, pricing, and strategic partnerships. The competitive landscape in the industry is dynamic, with constant new product launches and geographic expansions to maintain market positions.

GenScript offers clients the opportunity to verify the effectiveness of antibodies in their specific application prior to proceeding with the sequencing of desired clones for recombinant antibody production.

Illumina aims to utilize cutting-edge technologies in order to analyze genetic variation and function, enabling studies that were previously unimaginable. It provides adaptable and scalable solutions to cater to the customers' requirements.

Gene Panel Market Top Key Companies:

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• QIAGEN N.V.
• BGI Genomics Co., Ltd.
• Eurofins Scientific SE
• GENEWIZ, Inc.
• Novogene Corporation
• Personalis, Inc.
• F. Hoffmann-La Roche Ltd.

Gene Panel Market Recent Development

• In May 2024, 10x Genomics introduced the Xenium Prime 5K Pan-Tissue and Pathways panel, revolutionizing single-cell analysis with a major plex increase and industry-best speed and throughput, allowing for detailed exploration of cellular biology and disease mechanisms.
• In May 2023, Vizgen launched two predesigned MERFISH gene panels, PanCancer Pathways and PanNeuro Cell Type, at the AACR 2023, providing a convenient starting point for researchers to explore spatial genomics. The panels feature curated lists of genes from published literature and databases, enabling studies on cancer and brain biology.
• In April 2023, Agilent Technologies, Inc. announced the launch of the SureSelect Cancer CGP Assay, an NGS panel for comprehensive genomic profiling of solid tumors. The assay features 679 globally curated genes, including somatic variants and immuno-oncology biomarkers, and can be automated for efficient workflow and high-performance results.

Gene Panel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Gene Panel market.

By Product & Services 

• Test Kits
• Testing Services

By Technique 

• Amplicon-based Approach
• Hybridization-based Approach

By Design 

• Predesigned Gene Panel
• Customized Gene Panel

By Application 

• Cancer Risk Assessment
• Syndrome Specific
• High Penetrance
• High & Moderate Penetrance
• Comprehensive Cancer Risk
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

By End Use 

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)